Lung Cancer News

The addition of immunotherapy to perioperative conventional cancer therapy appeared linked to more grade 3 to grade 4 treatment related adverse events, according to findings published in The Lancet Oncology.

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

A randomized phase 3 study designed to assess sacituzumab govitecan-hziy for treatment of previously treated metastatic non-small cell lung cancer failed to meet its primary endpoint of OS, according to the agent’s manufacturer.

The American Cancer Society presented its 2024 Medal of Honor to Pasi A. Jänne, MD, PhD.

A preclinical study conducted at the Icahn School of Medicine at Mount Sinai has found an allergy pathway that, when blocked, triggers antitumor immunity in mouse models of non-small cell lung cancer.

In this edition, FDA places hold on cell therapy trial after patient death, selpercatinib delivers superior outcomes and more.

Postoperative mortality rates in patients who had surgical resection of non-small cell lung cancer dropped significantly with Medicaid expansion under the Patient Protection and Affordable Care Act, per a study in JAMA Network Open.

Narjust Florez, MD, vividly recalls the urgent message she received from a colleague 3 years ago.

Homeless veterans with lung or colorectal cancers had higher mortality rates than housed veterans, study data published in JAMA Network Open showed.

Between 1990 and 2019, global age-standardized incidence and mortality rates of mesothelioma went down, according to results published in Annals of the American Thoracic Society.